Ben Pradhan
Orthopaedic Surgery of the Spine · Pasadena, CANPI 1821042987
Payments from drug & device makers
What this record shows
This record is dominated by other: $686,376 of the $693,518 with a category attached, or 99.0%. Depuy Synthes Products, Inc. accounts for 99.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $638,721 and has fallen 99.9% since, to $462 in 2024.
Across 60 payments — averaging $11,559 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$686K
- Globus Medical$6K
- Medtronic$823
- Pacira Therapeutics, Inc.$114
- Si-bone, Inc.$54
- Boston Scientific$53
- plus $161 from 6 others
Across 2 payments — averaging $55,300 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Skye Orthobiologics LLC$111K
What the payments were for
- Royalty or licence$5,9081%
- Food & beverage$1,2350%
- Other$686,37699%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 3 | $686,376 |
| Globus Medical | 17 | $5,937 |
| Medtronic(2 entities) | 31 | $823 |
| Pacira Therapeutics, Inc. | 1 | $114 |
| Si-bone, Inc. | 1 | $54 |
| Boston Scientific | 1 | $53 |
| Camber Spine Technologies LLC | 1 | $46 |
| Integra Lifesciences Corporation | 1 | $27 |
| AbbVie | 1 | $26 |
| Molnlycke Health Care US, LLC | 1 | $23 |
| Abbott | 1 | $21 |
| Nevro Corp. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$693,518 in reported general payments places this provider in the 85th percentile of 288 orthopaedic surgery of the spine providers in California.
See all orthopaedic surgery of the spine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 103 | $1,017 |
| Cyclobenzaprine Hcl | 101 | $877 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 117 | $273 |
| Methylprednisolone | 42 | $257 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $139 |
| Gabapentin | 19 | $71 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Pasadena
- Walter BurnhamPasadena$384K
- Hyun BaeSanta Monica$56.8M
- Choll KimSan Diego$4M
- Stacey BedermanOrange$3.7M
- Gregory Mundisla Jolla$3.3M
- Paul SlosarDaly City$3.1M
- Babak Barcohanavan Nuys$2.9M
- Neelakantan AnandLos Angeles$2.9M
- Sanjay KhuranaMarina del Rey$2.3M
- Neville AlleyneOceanside$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.